Is Yasmin as safe as other contraceptive pills? [2]

Clinical and Applied Thrombosis/Hemostasis

Volumn 12, Issue 3, 2006, Pages 378-379

  Mira, Yolanda ^a   Morata, Carmen ^b   Vayá, Amparo ^a   Ferrando, Fernando ^a   Contreras, Teresa ^a   Aznar, Justo ^a  

^a Department of Clinical Pathology ^*

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; DROSPIRENONE PLUS ETHINYLESTRADIOL; NADROPARIN; ORAL CONTRACEPTIVE AGENT;

ADULT; CASE REPORT; COLD CLAMMY SKIN; DRUG SAFETY; DYSMENORRHEA; ECHOGRAPHY; EDEMA; ELECTROMYOGRAPHY; FEMALE; HUMAN; LETTER; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PARESTHESIA; PHLEBOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VEIN THROMBOSIS;

ADULT; ANDROSTENES; CONTRACEPTIVE AGENTS; EDEMA; FEMALE; HUMANS; PAIN; VENOUS THROMBOSIS;

EID: 33748747681     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029606291424     Document Type: Letter

References (11)

1. Thorneycroft IH. Yasmin: the reason why. Eur J Contracept Reprod Health Care 2000;(Suppl 3):13.
2. Aznar J, Mira Y, Vayá A. Anticonceptivos orales y riesgo tromboembólico. Haematologica 2000;(Suppl 2):208.
3. Rosendaal F, Helmerhorst F, Vanderbroucke J. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002;22:201.
4. Aznar J, Vayá A, Estellés A, et al. Risk of venous thrombosis in carriers of the prothrombin G20210 A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica 2000;85:1271.
5. Weiss G. Risk of venous thromboembolism with third generation oral contraceptives: A review. Am J Obstet Gynecol 1999;180:295.
6. Sheldon T. Dutch GPs warned against new contraceptive pill. BMJ 2002;324:869.
7. Yuzpe AA. Oral contraception: Trends over time. J Reprod Med 2002;47(Suppl 11):967.
8. Vayá A, Mira Y, Ferrando F, et al. Transient ischaemic attack associated with the new contraceptive Yasmin. Thromb Res 2003;112:21.
9. Koning R, Cribier A, Gerber L, et al. A new treatment for severe pulmonary embolism. Percutaneous rheolytic thrombectomy. Circulation 1997;96:2498.
10. Vayá A, Mira Y, Mateo J, et al. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Thromb Haemost 2003;89:452.
11. Medicines Evaluation Board. Statement on Yasmin and VTE risk. Available in Dutch at: http://www.cbg-meb.nl/ under Nieuws en Publicities, 28 Maart 2002. Accessed May 2003.